Future research in ITP: An ICIS consensus

James L. Zehnder, John W. Semple, Paul Imbach, Ellis J. Neufeld, George R. Buchanan, Douglas B. Cines

Research output: Contribution to journalArticle

4 Scopus citations


While much has been learned about the basic immunology and clinical characteristics of immune thrombocytopenia, many important questions remain with regard to pathogenesis, disease progression, identification of novel therapeutic targets and approaches, and clinical trials that rationalize and optimize use of existing therapies. The answers to these questions are likely to impact our understanding of the pathogenesis and therapeutic targets of autoimmune disease in general.

Original languageEnglish (US)
JournalAnnals of Hematology
Issue numberSUPPL. 1
Publication statusPublished - Jul 2010



  • Autoimmune diseases
  • Immune thrombocytopenia
  • ITP

ASJC Scopus subject areas

  • Hematology

Cite this

Zehnder, J. L., Semple, J. W., Imbach, P., Neufeld, E. J., Buchanan, G. R., & Cines, D. B. (2010). Future research in ITP: An ICIS consensus. Annals of Hematology, 89(SUPPL. 1). https://doi.org/10.1007/s00277-010-0917-1